• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核分枝杆菌:免疫逃避、潜伏和再激活。

Mycobacterium tuberculosis: immune evasion, latency and reactivation.

机构信息

Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck, University of London, London WC1E 7HX, UK.

出版信息

Immunobiology. 2012 Mar;217(3):363-74. doi: 10.1016/j.imbio.2011.07.008. Epub 2011 Jul 18.

DOI:10.1016/j.imbio.2011.07.008
PMID:21813205
Abstract

One-third of the global human population harbours Mycobacterium tuberculosis in dormant form. This dormant or latent infection presents a major challenge for global efforts to eradicate tuberculosis, because it is a vast reservoir of potential reactivation and transmission. This article explains how the pathogen evades the host immune response to establish a latent infection, and how it emerges from a state of latency to cause reactivation disease. This review highlights the key factors responsible for immune evasion and reactivation. It concludes by identifying interesting candidates for drug or vaccine development, as well as identifying unresolved questions for the future research.

摘要

全球有三分之一的人口携带有处于休眠状态的结核分枝杆菌。这种休眠或潜伏感染对全球消除结核病的努力构成了重大挑战,因为它是潜在再激活和传播的巨大储存库。本文解释了病原体如何逃避宿主免疫反应以建立潜伏感染,以及它如何从潜伏状态中出现导致再激活疾病。这篇综述强调了负责免疫逃避和再激活的关键因素。最后,它确定了药物或疫苗开发的有趣候选者,并确定了未来研究中未解决的问题。

相似文献

1
Mycobacterium tuberculosis: immune evasion, latency and reactivation.结核分枝杆菌:免疫逃避、潜伏和再激活。
Immunobiology. 2012 Mar;217(3):363-74. doi: 10.1016/j.imbio.2011.07.008. Epub 2011 Jul 18.
2
The immunological aspects of latency in tuberculosis.结核病潜伏感染的免疫学方面。
Clin Immunol. 2004 Jan;110(1):2-12. doi: 10.1016/s1521-6616(03)00210-9.
3
Fighting Persistence: How Chronic Infections with Mycobacterium tuberculosis Evade T Cell-Mediated Clearance and New Strategies To Defeat Them.与结核分枝杆菌的慢性感染作斗争:细胞介导的清除如何逃避以及击败它们的新策略。
Infect Immun. 2020 Jun 22;88(7). doi: 10.1128/IAI.00916-19.
4
Immune evasion by Mycobacterium tuberculosis: living with the enemy.结核分枝杆菌的免疫逃逸:与敌人共存
Curr Opin Immunol. 2003 Aug;15(4):450-5. doi: 10.1016/s0952-7915(03)00075-x.
5
Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.结核分枝杆菌对抗抗原呈递的逃避与颠覆
Tissue Antigens. 2009 Sep;74(3):189-204. doi: 10.1111/j.1399-0039.2009.01301.x. Epub 2009 Jun 25.
6
Host evasion and exploitation schemes of Mycobacterium tuberculosis.结核分枝杆菌的宿主逃避和利用策略。
Cell. 2014 Dec 18;159(7):1497-509. doi: 10.1016/j.cell.2014.11.024.
7
Deciphering tuberculosis: lysosome-centric insights into pathogenesis and therapies.解读结核病:以溶酶体为中心对发病机制和治疗方法的见解
Front Cell Infect Microbiol. 2025 May 14;15:1582037. doi: 10.3389/fcimb.2025.1582037. eCollection 2025.
8
Natural and trained innate immunity against Mycobacterium tuberculosis.天然和训练有素的固有免疫对抗结核分枝杆菌。
Immunobiology. 2020 May;225(3):151951. doi: 10.1016/j.imbio.2020.151951. Epub 2020 Apr 27.
9
[Mycobacterium tuberculosis virulence factors and its immune evasion mechanisms].[结核分枝杆菌毒力因子及其免疫逃逸机制]
Mikrobiyol Bul. 2004 Jan-Apr;38(1-2):155-67.
10
Immunoevasion and immunosuppression of the macrophage by Mycobacterium tuberculosis.结核分枝杆菌对巨噬细胞的免疫逃逸和免疫抑制。
Immunol Rev. 2015 Mar;264(1):220-32. doi: 10.1111/imr.12268.

引用本文的文献

1
mTORC2 is crucial for regulating the recombinant Mycobacterium tuberculosis CFP-10 protein-induced phagocytosis in macrophages.mTORC2对于调节重组结核分枝杆菌CFP-10蛋白诱导的巨噬细胞吞噬作用至关重要。
BMC Immunol. 2025 May 9;26(1):36. doi: 10.1186/s12865-025-00715-6.
2
Utilizing artificial intelligence to predict and analyze socioeconomic, environmental, and healthcare factors driving tuberculosis globally.利用人工智能预测和分析全球范围内推动结核病传播的社会经济、环境和医疗因素。
Sci Rep. 2025 Apr 19;15(1):13619. doi: 10.1038/s41598-025-96973-w.
3
Applications of Biological Therapy for Latent Infections: Benefits and Risks.
生物疗法在潜伏感染中的应用:益处与风险。
Int J Mol Sci. 2024 Aug 24;25(17):9184. doi: 10.3390/ijms25179184.
4
Decreased IL-1 β Secretion as a Potential Predictor of Tuberculosis Recurrence in Individuals Diagnosed with HIV.白细胞介素-1β分泌减少作为诊断为HIV的个体结核病复发的潜在预测指标。
Biomedicines. 2024 Apr 25;12(5):954. doi: 10.3390/biomedicines12050954.
5
Unique Profile of Proinflammatory Cytokines in Plasma of Drug-Naïve Individuals with Advanced HIV/TB Co-Infection.在未经药物治疗的晚期 HIV/TB 合并感染个体的血浆中存在独特的促炎细胞因子谱。
Viruses. 2023 Jun 6;15(6):1330. doi: 10.3390/v15061330.
6
Mycobacterial Regulatory Systems Involved in the Regulation of Gene Expression Under Respiration-Inhibitory Conditions.参与呼吸抑制条件下基因表达调控的分枝杆菌调节系统。
J Microbiol. 2023 Mar;61(3):297-315. doi: 10.1007/s12275-023-00026-8. Epub 2023 Feb 27.
7
Evaluating the Performance of PPE44, HSPX, ESAT-6 and CFP-10 Factors in Tuberculosis Subunit Vaccines.评估 PPE44、HSPX、ESAT-6 和 CFP-10 因子在结核病亚单位疫苗中的性能。
Curr Microbiol. 2022 Jul 19;79(9):260. doi: 10.1007/s00284-022-02949-8.
8
Immunobiology of tubercle bacilli and prospects of immunomodulatory drugs to tackle tuberculosis (TB) and other non-tubercular mycobacterial infections.结核分枝杆菌的免疫生物学及免疫调节剂药物在结核病(TB)和其他非结核分枝杆菌感染治疗中的应用前景。
Immunobiology. 2022 May;227(3):152224. doi: 10.1016/j.imbio.2022.152224. Epub 2022 May 5.
9
The Biological and Clinical Aspects of a Latent Tuberculosis Infection.潜伏性结核感染的生物学及临床特征
Trop Med Infect Dis. 2022 Mar 8;7(3):48. doi: 10.3390/tropicalmed7030048.
10
The Dynamic Change of Immune Checkpoints and CD14+ Monocytes in Latent Tuberculosis Infection.潜伏性结核感染中免疫检查点和CD14+单核细胞的动态变化
Biomedicines. 2021 Oct 15;9(10):1479. doi: 10.3390/biomedicines9101479.